300633 开立医疗
已收盘 11-05 15:00:00
资讯
新帖
简况
开立医疗(300633)10月30日主力资金净买入449.52万元
证券之星 · 11-02
开立医疗(300633)10月30日主力资金净买入449.52万元
开立医疗(300633)2026年三季报简析:增收不增利,公司应收账款体量较大
证券之星 · 10-31
开立医疗(300633)2026年三季报简析:增收不增利,公司应收账款体量较大
【机构调研记录】国海富兰克林基金调研恒辉安防、开立医疗等8只个股(附名单)
证券之星 · 10-30
【机构调研记录】国海富兰克林基金调研恒辉安防、开立医疗等8只个股(附名单)
【机构调研记录】兴银基金管理调研开立医疗
证券之星 · 10-30
【机构调研记录】兴银基金管理调研开立医疗
股市必读:开立医疗三季报 - 第三季度单季净利润同比增长83.16%
证券之星 · 10-30
股市必读:开立医疗三季报 - 第三季度单季净利润同比增长83.16%
开立医疗:10月29日接受机构调研,国联民生证券、东北证券等多家机构参与
证券之星 · 10-29
开立医疗:10月29日接受机构调研,国联民生证券、东北证券等多家机构参与
开立医疗:公司成立了专门的数字信息部门
证券之星 · 10-29
开立医疗:公司成立了专门的数字信息部门
开立医疗:公司通过实施外币理财等方式部分对冲外币贬值的风险
证券之星 · 10-29
开立医疗:公司通过实施外币理财等方式部分对冲外币贬值的风险
图解开立医疗三季报:第三季度单季净利润同比增长83.16%
证券之星 · 10-29
图解开立医疗三季报:第三季度单季净利润同比增长83.16%
开立医疗(300633)10月26日主力资金净卖出1155.68万元
证券之星 · 10-27
开立医疗(300633)10月26日主力资金净卖出1155.68万元
开立医疗(300633)10月23日主力资金净买入1342.19万元
证券之星 · 10-26
开立医疗(300633)10月23日主力资金净买入1342.19万元
10月23日开立医疗涨6.84%,金信深圳成长混合A基金重仓该股
证券之星 · 10-23
10月23日开立医疗涨6.84%,金信深圳成长混合A基金重仓该股
开立医疗涨6.84%,太平洋一个月前给出“买入”评级
证券之星 · 10-23
开立医疗涨6.84%,太平洋一个月前给出“买入”评级
开立医疗(300633)10月21日主力资金净卖出394.25万元
证券之星 · 10-22
开立医疗(300633)10月21日主力资金净卖出394.25万元
开立医疗(300633)10月16日主力资金净买入538.42万元
证券之星 · 10-19
开立医疗(300633)10月16日主力资金净买入538.42万元
10月15日开立医疗涨5.55%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-15
10月15日开立医疗涨5.55%,融通健康产业灵活配置混合A/B基金重仓该股
开立医疗涨5.55%,太平洋一个月前给出“买入”评级
证券之星 · 10-15
开立医疗涨5.55%,太平洋一个月前给出“买入”评级
股市必读:开立医疗新发布《关于控股股东部分股份质押的公告》
证券之星 · 10-15
股市必读:开立医疗新发布《关于控股股东部分股份质押的公告》
开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%
证券之星 · 10-14
开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%
开立医疗(300633)10月13日主力资金净买入43.34万元
证券之星 · 10-14
开立医疗(300633)10月13日主力资金净买入43.34万元
加载更多
公司概况
公司名称:
深圳开立生物医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2017-04-06
主营业务:
深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品以及心血管介入产品。截至报告期末,公司及其子公司已拥有境内外各项发明专利、实用新型专利及外观设计专利共计1254项,拥有软件著作权共344项、作品著作权30项,产品技术达到国内领先和国际先进水平。公司自2009年起被持续认定为“国家级高新技术企业”。
发行价格:
5.23
{"stockData":{"symbol":"300633","market":"SZ","secType":"STK","nameCN":"开立医疗","latestPrice":22.48,"timestamp":1793862201000,"preClose":21.59,"halted":0,"volume":9574232,"delay":0,"changeRate":0.0412,"floatShares":260000000,"shares":425000000,"eps":0.4126,"marketStatus":"已收盘","change":0.89,"latestTime":"11-05 15:00:00","open":21.6,"high":22.52,"low":21.35,"amount":212000000,"amplitude":0.0542,"askPrice":22.48,"askSize":6,"bidPrice":22.47,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.4126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":5,"adr":0,"adjPreClose":21.59,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":23.75,"lowLimit":19.43,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":424837505,"isCdr":false,"pbRate":3.04,"roa":"--","peRate":54.483762,"roe":"0.34%","epsLYR":0.46,"committee":-0.805882,"marketValue":9550000000,"turnoverRate":0.0368,"status":0,"floatMarketCap":5847000000},"requestUrl":"/m/hq/s/300633","defaultTab":"news","newsList":[{"id":"2680786927","title":"开立医疗(300633)10月30日主力资金净买入449.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786927?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:07","pubTimestamp":1793581651,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月30日收盘,开立医疗报收于21.6元,上涨2.18%,换手率3.42%,成交量8.9万手,成交额1.93亿元。10月30日的资金流向数据方面,主力资金净流入449.52万元,占总成交额2.33%,游资资金净流出211.36万元,占总成交额1.09%,散户资金净流出238.17万元,占总成交额1.23%。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999001051.SGD","SG9999006597.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226807","title":"开立医疗(300633)2026年三季报简析:增收不增利,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226807?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:53","pubTimestamp":1793404402,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期开立医疗发布2026年三季报。截至本报告期末,公司营业总收入15.88亿元,同比上升8.85%,归母净利润1149.96万元,同比下降65.68%。本报告期开立医疗公司应收账款体量较大,当期应收账款占最新年报归母净利润比达140.47%。前三季度公司国际和国内业务收入均同比保持增长,国际与国内收入占比各约 50%。腔镜市场排名,开立排名第四,有望向第三名发起挑战。前三季度公司整体毛利率 60.7%,自去年Q3、Q4起已基本企稳。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","BK0251","SG9999001069.SGD","SG9999006597.SGD","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679255818","title":"【机构调研记录】国海富兰克林基金调研恒辉安防、开立医疗等8只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679255818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679255818?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:02","pubTimestamp":1793318542,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月29日披露的机构调研信息,国海富兰克林基金近期对8家上市公司进行了调研,相关名单如下:1)恒辉安防 调研纪要:公司机器人业务板块目前主要围绕仿生腱绳、柔性织物防护件、机器人皮肤、数据采集手套等柔性配套产品布局,聚焦人形机器人柔性执行层方案。8)云图控股 调研纪要:前三季度,公司复合肥毛利率同比略有增长,新型复合肥销量与毛利率均提升,产品结构持续优化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300952","300633","SG9999001051.SGD","SG9999006597.SGD","SG9999001069.SGD","BK0247","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679825303","title":"【机构调研记录】兴银基金管理调研开立医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2679825303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679825303?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:01","pubTimestamp":1793318496,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月29日披露的机构调研信息,兴银基金管理近期对1家上市公司进行了调研,相关名单如下:1)开立医疗 调研纪要:公司前三季度营收15.88亿元,同比增长8.85%,净利润1150万元,剔除汇兑损失后业务端利润同比增长约200%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300633","SG9999001051.SGD","SG9999006597.SGD","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679237800","title":"股市必读:开立医疗三季报 - 第三季度单季净利润同比增长83.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679237800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679237800?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:32","pubTimestamp":1793309571,"startTime":"0","endTime":"0","summary":"第三季度单季度主营收入5.35亿元,同比上升8.1%;归母净利润-227.67万元,同比上升83.16%;扣非净利润-450.34万元,同比上升71.65%;负债率27.09%,毛利率60.76%,财务费用3302.43万元,投资收益126.35万元。公司公告汇总2026年三季度报告本报告期营业收入535,135,609.29元,同比增长8.10%;年初至报告期末1,588,458,126.43元,同比增长8.85%。关于2025年员工持股计划第一个归属期权益归属的公告2025年度剔除股份支付费用后的净利润为20,038.62万元,同比增长46.81%,达第一个归属期业绩考核目标,归属比例为100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000007469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679406052","title":"开立医疗:10月29日接受机构调研,国联民生证券、东北证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2679406052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679406052?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:38","pubTimestamp":1793273927,"startTime":"0","endTime":"0","summary":"前三季度公司整体毛利率 60.7%,自去年Q3、Q4起已基本企稳。随着产品结构向高端化演进及规模效应显现,预计毛利率将保持稳中微升态势。其一,对企业毛利率有影响公司超声毛利率已从原来的 65%—66%降至 60%出头,但通过产品结构调整已基本企稳。其二,行业毛利率将分化国家已出台政策反对单纯低价中标,只有坚持高端化、专科化并抢占国际品牌份额的企业才能稳住毛利率,做不到的企业将被集采和价格竞争持续拖低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900047884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","601456","BK0276","BK0183","SG9999006597.SGD","161027","01456","BK1564","BK1147","SG9999001051.SGD","300633","SG9999001069.SGD","BK0188","000686","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679660420","title":"开立医疗:公司成立了专门的数字信息部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2679660420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679660420?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:03","pubTimestamp":1793260989,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗(300633)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,我是公司的小股东/投资者,想了解一下贵公司2025-2026年‘信息化建设’相关情况。请问公司目前IT/数字化团队的规模大概是多少人?年度信息化投入金额大约是多少?这些信息在财报中未单独披露,能否告知大致范围?开立医疗回复:您好,公司成立了专门的数字信息部门,对全公司的ERP、OA等系统进行支持和维护,保证公司业务和各项工作高效运转,具体投入金额未进行专项统计,谢谢。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900037023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","300633","SG9999006597.SGD","SG9999001069.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679612420","title":"开立医疗:公司通过实施外币理财等方式部分对冲外币贬值的风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2679612420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679612420?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:00","pubTimestamp":1793260844,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗(300633)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,公司上半年汇兑损失大幅冲击公司业绩,当前人民币持续升值,公司有哪些新举措因减少汇兑损失对业绩的冲击?开立医疗回复:您好,公司通过实施外币理财等方式部分对冲外币贬值的风险,谢谢。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900036723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999006597.SGD","BK0251","300633","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679133984","title":"图解开立医疗三季报:第三季度单季净利润同比增长83.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679133984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679133984?lang=zh_cn&edition=full","pubTime":"2026-10-29 02:30","pubTimestamp":1793212206,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗2026年三季报显示,前三季度公司主营收入15.88亿元,同比上升8.85%;归母净利润1149.96万元,同比下降65.68%;扣非净利润-201.81万元,同比下降108.41%;其中2026年第三季度,公司单季度主营收入5.35亿元,同比上升8.1%;单季度归母净利润-227.67万元,同比上升83.16%;单季度扣非净利润-450.34万元,同比上升71.65%;负债率27.09%,投资收益126.35万元,财务费用3302.43万元,毛利率60.76%。财报数据概要请见下图:本文数据来源于开立医疗2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678409143","title":"开立医疗(300633)10月26日主力资金净卖出1155.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678409143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678409143?lang=zh_cn&edition=full","pubTime":"2026-10-27 09:11","pubTimestamp":1793063471,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月26日收盘,开立医疗报收于21.79元,上涨2.59%,换手率4.65%,成交量12.09万手,成交额2.64亿元。10月26日的资金流向数据方面,主力资金净流出1155.68万元,占总成交额4.37%,游资资金净流入230.76万元,占总成交额0.87%,散户资金净流入924.93万元,占总成交额3.5%。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700011407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999006597.SGD","300633","BK0251","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678713794","title":"开立医疗(300633)10月23日主力资金净买入1342.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678713794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678713794?lang=zh_cn&edition=full","pubTime":"2026-10-26 09:07","pubTimestamp":1792976834,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月23日收盘,开立医疗报收于21.24元,上涨6.84%,换手率5.79%,成交量15.06万手,成交额3.13亿元。10月23日的资金流向数据方面,主力资金净流入1342.19万元,占总成交额4.29%,游资资金净流出947.01万元,占总成交额3.03%,散户资金净流出395.17万元,占总成交额1.26%。融券方面,融券卖出6400.0股,融券偿还1.77万股,融券余量10.56万股,融券余额224.29万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600003138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999001051.SGD","BK0251","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677294408","title":"10月23日开立医疗涨6.84%,金信深圳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677294408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677294408?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:50","pubTimestamp":1792745427,"startTime":"0","endTime":"0","summary":"证券之星消息,10月23日开立医疗涨6.84%创60日新高,收盘报21.24元,换手率5.79%,成交量15.06万手,成交额3.13亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为金信基金的金信深圳成长混合A。金信深圳成长混合A目前规模为6.86亿元,最新净值3.4324,较上一交易日下跌1.17%,近一年上涨22.06%。金信深圳成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999001069.SGD","SG9999006597.SGD","BK0251","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677944056","title":"开立医疗涨6.84%,太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2677944056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677944056?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:50","pubTimestamp":1792745411,"startTime":"0","endTime":"0","summary":"今日开立医疗涨6.84%,收盘报21.24元。2026年8月24日,太平洋研究员谭紫媚发布了对开立医疗的研报《开立医疗:新业务增长态势良好,股权激励彰显发展信心》,该研报对开立医疗给出“买入”评级。研报中预计公司2026/2027/2028年营业收入分别为26.32/30.09/34.58亿元,同比增速为13.97%/14.35%/14.90%;归母净利润为3.39/4.29/5.46亿元,同比增速为71.80%/26.49%/27.45%。对应EPS分别为0.80/1.01/1.29元,对应当前股价PE分别为26/21/16倍,维持“买入”评级。开立医疗个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","601099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677998190","title":"开立医疗(300633)10月21日主力资金净卖出394.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677998190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677998190?lang=zh_cn&edition=full","pubTime":"2026-10-22 09:19","pubTimestamp":1792631949,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月21日收盘,开立医疗报收于19.38元,下跌2.42%,换手率1.63%,成交量4.23万手,成交额8310.08万元。10月21日的资金流向数据方面,主力资金净流出394.25万元,占总成交额4.74%,游资资金净流出47.82万元,占总成交额0.58%,散户资金净流入442.06万元,占总成交额5.32%。融券方面,融券卖出1000.0股,融券偿还1300.0股,融券余量8.98万股,融券余额174.03万元。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200008235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","BK0251","300633","SG9999001069.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676579744","title":"开立医疗(300633)10月16日主力资金净买入538.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676579744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676579744?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:13","pubTimestamp":1792372439,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,开立医疗报收于18.72元,下跌4.39%,换手率3.32%,成交量8.65万手,成交额1.68亿元。10月16日的资金流向数据方面,主力资金净流入538.42万元,占总成交额3.2%,游资资金净流入965.66万元,占总成交额5.74%,散户资金净流出1504.08万元,占总成交额8.95%。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","300633","SG9999006597.SGD","SG9999001069.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675075533","title":"10月15日开立医疗涨5.55%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675075533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675075533?lang=zh_cn&edition=full","pubTime":"2026-10-15 16:45","pubTimestamp":1792053919,"startTime":"0","endTime":"0","summary":"证券之星消息,10月15日开立医疗涨5.55%,收盘报19.58元,换手率3.75%,成交量9.75万手,成交额1.87亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500027718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001069.SGD","BK0251","300633","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675307354","title":"开立医疗涨5.55%,太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2675307354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675307354?lang=zh_cn&edition=full","pubTime":"2026-10-15 16:45","pubTimestamp":1792053911,"startTime":"0","endTime":"0","summary":"今日开立医疗涨5.55%,收盘报19.58元。2026年8月24日,太平洋研究员谭紫媚发布了对开立医疗的研报《开立医疗:新业务增长态势良好,股权激励彰显发展信心》,该研报对开立医疗给出“买入”评级。对应EPS分别为0.80/1.01/1.29元,对应当前股价PE分别为26/21/16倍,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为38.02%。开立医疗个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500027717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675324803","title":"股市必读:开立医疗新发布《关于控股股东部分股份质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675324803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675324803?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:03","pubTimestamp":1792004591,"startTime":"0","endTime":"0","summary":"公司公告汇总关于控股股东部分股份质押的公告深圳开立生物医疗科技股份有限公司控股股东吴坤祥将其持有的公司1,200,000股股份质押给中国中金财富证券有限公司,占其所持股份比例1.25%,占公司总股本比例0.28%,质押用途为个人资金需求。控股股东陈志强、吴坤祥合计累计质押股份18,330,000股,占二人所持股份比例9.57%,占公司总股本比例4.31%。上述质押股份不存在限售、冻结、拍卖或设定信托等情况,目前不存在平仓风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500002094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999001051.SGD","SG9999006597.SGD","SG9999001069.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675439053","title":"开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675439053","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675439053?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:24","pubTimestamp":1791973471,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗10月14日公开信息显示,股东吴坤祥向中国中金财富证券有限公司合计质押120.0万股,占总股本0.28%。质押详情见下表:截止本公告日,股东吴坤祥已累计质押股份1100.0万股,占其持股总数的11.49%,股东陈志强已累计质押股份733.0万股,占其持股总数的7.66%,股东黄奕波已累计质押股份160.0万股,占其持股总数的7.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400033321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001069.SGD","BK0251","300633","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399929","title":"开立医疗(300633)10月13日主力资金净买入43.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399929?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:14","pubTimestamp":1791940464,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,开立医疗报收于18.66元,下跌2.51%,换手率1.44%,成交量3.73万手,成交额6987.31万元。10月13日的资金流向数据方面,主力资金净流入43.34万元,占总成交额0.62%,游资资金净流入860.67万元,占总成交额12.32%,散户资金净流出904.01万元,占总成交额12.94%。融券方面,融券卖出4700.0股,融券偿还3.01万股,融券余量9.29万股,融券余额173.35万元。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999001051.SGD","BK0251","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793916310303,"stockEarnings":[{"period":"1week","weight":0.0634},{"period":"1month","weight":0.1576},{"period":"3month","weight":0.1058},{"period":"6month","weight":-0.0578},{"period":"1year","weight":-0.2036},{"period":"ytd","weight":-0.1412}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳开立生物医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"19299人(较上一季度增加2.04%)","perCapita":"13478股","listingDate":"2017-04-06","address":"广东省深圳市南山区粤海街道麻岭社区高新中区科技中2路1号深圳软件园(2期)12栋201、202","registeredCapital":"42483万元","survey":" 深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品以及心血管介入产品。截至报告期末,公司及其子公司已拥有境内外各项发明专利、实用新型专利及外观设计专利共计1254项,拥有软件著作权共344项、作品著作权30项,产品技术达到国内领先和国际先进水平。公司自2009年起被持续认定为“国家级高新技术企业”。","listedPrice":5.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开立医疗,300633,开立医疗股票,开立医疗股票老虎,开立医疗股票老虎国际,开立医疗行情,开立医疗股票行情,开立医疗股价,开立医疗股市,开立医疗股票价格,开立医疗股票交易,开立医疗股票购买,开立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}